Hydrogels Containing Chitosan-Modified Gold Nanoparticles Show Significant Efficacy in Healing Diabetic Wounds Infected with Antibiotic-Resistant Bacteria
Hongqi Meng,Ying Zhao,Hang Cai,Di You,Ying Wang,Siyu Wu,Yixin Wang,Wenlai Guo,Wenrui Qu
DOI: https://doi.org/10.2147/ijn.s448282
IF: 7.033
2024-02-19
International Journal of Nanomedicine
Abstract:Hongqi Meng, 1 Ying Zhao, 1 Hang Cai, 2 Di You, 3 Ying Wang, 4 Siyu Wu, 1 Yixin Wang, 5 Wenlai Guo, 1 Wenrui Qu 1, 6 1 Department of Hand Surgery, The Second Hospital of Jilin University, Changchun, 130041, People's Republic of China; 2 Department of Pharmacy, The Second Hospital of Jilin University, Changchun, 130041, People's Republic of China; 3 Department of Anesthesiology, China-Japan Union Hospital of Jilin University, Changchun, 130031, People's Republic of China; 4 Institute of Neural Tissue Engineering, Mudanjiang College of Medicine, Mudanjiang, 157011, People's Republic of China; 5 Department of Plastic Surgery, First Hospital of Jilin University, Changchun, 130021, People's Republic of China; 6 Joint International Research Laboratory of Ageing Active Strategy and Bionic Health in Northeast Asia of Ministry of Education, Jilin University, Changchun, 130041, People's Republic of China Correspondence: Wenlai Guo, Email Purpose: Persistent Infections and inflammation are associated with impaired wound healing in diabetic patients. There is a pressing demand for innovative antimicrobial strategies to address infections arising from antibiotic-resistant bacteria. Polymer-modified gold nanoparticles (AuNPs) show broad-spectrum antibacterial properties and significant biocompatibility. This study investigated the antibacterial and wound healing efficacy of hydrogel dressings conjugated with chitosan-AuNPs in diabetic model rats. Methods: Chitosan (CS)-functionalized gold nanoparticles (CS-AuNPs) were incorporated into hydrogel dressings (Gel/CS-AuNPs), which were formulated through the chemical cross-linking of gelatin with sodium alginate (SA). The basic characteristics of Gel/CS-AuNPs were analyzed by TEM, SEM, XRD, and UV-visible spectra. Rheological, swelling, degradation, and adhesive properties of Gel/CS-AuNPs were also determined. In vitro anti-bactericidal effects of the Gel/CS-AuNPs were analyzed with E. coli, S. aureus , and MRSA . In vitro biocompatibility of the Gel/CS-AuNPs was evaluated using NIH3T3 cells. The in vivo antibacterial and wound healing efficacy of the Gel/CS-AuNPs was analyzed in the diabetic wound model rats. Histological and immunofluorescence staining were performed to determine the status of angiogenesis, epithelization, inflammation response, and collagen deposition. Results: Gel/CS-AuNPs demonstrated significant high biodegradability, water absorption bactericidal, and biocompatibility, and slight adhesiveness. Gel/CS-AuNPs exhibited pronounced antibacterial efficacy against gram-negative, gram-positive, and MRSA in a CS-AuNPs-dose-dependent manner. In the diabetic wound model rats, Gel/CS-AuNPs effectively killed MRSA , reduced inflammation, and promoted angiogenesis and collagen deposition and remodeling at the wound site. As a result, Gel/CS-AuNPs expedited the recovery process for infected diabetic wounds. Among the hydrogels with different CS-AuNPs concentrations, Gel/CS-Au 25 with 25% CS-AuNPs showed the best bactericidal and wound healing performance. Conclusion: Gel/CS-AuNPs significantly improve the healing of MRSA -infected diabetic wounds in the rat model. Therefore, Gel/CS-AuNPs show great promise for the treatment of diabetic infection wound healing. Keywords: MRSA , infection, diabetic wounds, hydrogels, CS-AuNPs, antimicrobial Graphical Diabetes affects approximately 463 million individuals globally, with nearly a quarter of this population experiencing persistent, non-healing wounds. 1–3 Diabetic wounds are highly susceptible to bacterial infections that can induce inflammation, which inhibits angiogenesis and wound healing, thereby aggravating the blood flow disorder. 4–6 Clinically, the long-term use of antibiotics to control infections in diabetics has resulted in the emergence of drug-resistant bacterial strains. 4,7 Hence, there is a pressing demand for the innovation of novel, broad-spectrum, and low-toxic antimicrobial strategies that are effective in treating the infected wounds in diabetics. Inorganic nanoparticles show excellent antibacterial properties and do not easily develop drug resistance. 7,8 AuNPs are amenable to surface functionalization and show high biocompatibility and stability. 9,10 Free AuNPs do not show antibacterial properties. However, light stimulation or ligand modification can enhance the antibacterial activities of the AuNPs. 11–13 The ligand-modified AuNPs show antibacterial activity by disrupting the integrity of the bacterial membranes throu -Abstract Truncated-
pharmacology & pharmacy,nanoscience & nanotechnology